Page last updated: 2024-09-03

glabridin and Carcinoma, Non-Small Cell Lung

glabridin has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hsu, YL; Huang, MS; Hung, JY; Kuo, PL; Lien, CT; Tsai, YC; Tsai, YM; Wu, LY; Yang, CJ1

Other Studies

1 other study(ies) available for glabridin and Carcinoma, Non-Small Cell Lung

ArticleYear
Glabridin inhibits migration, invasion, and angiogenesis of human non-small cell lung cancer A549 cells by inhibiting the FAK/rho signaling pathway.
    Integrative cancer therapies, 2011, Volume: 10, Issue:4

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Focal Adhesion Protein-Tyrosine Kinases; Humans; Integrin beta3; Isoflavones; Lung Neoplasms; Mice; Mice, Nude; Myosin Light Chains; Neovascularization, Pathologic; Phenols; Phosphorylation; rhoA GTP-Binding Protein; Signal Transduction; src-Family Kinases

2011